Insider buying activity across five companies in Q1 2026 signals leadership confidence, though investors should weigh these internal trends against institutional support and analyst sentiment before making decisions.

Key Points

• E.W. Scripps (SSP) saw the highest volume of insider purchases in Q1, driven by a multiyear turnaround strategy focused on streaming media and debt reduction.
• Sumitomo Insurance Company increased its stake in W.R. Berkley (WRB) as part of a strategic expansion into the U.S. property insurance market.
• Service Properties Trust (SVC) directors acquired nearly 42 million shares, signaling confidence in the REIT’s hotel and service-station portfolio restructuring.
• Coupang (CPNG) faces technical headwinds following a major data breach, despite continued institutional accumulation and long-term international expansion goals.
• Korro Bio (KRRO) received broad-based insider support and positive analyst sentiment, with expectations for significant upside tied to upcoming gene-editing therapy milestones.

Why it Matters

Insider buying serves as a signal of management conviction, but it is most effective when corroborated by institutional accumulation and favorable analyst outlooks. Investors should use these internal transactions as a starting point for due diligence rather than a standalone indicator for portfolio adjustments.